Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 166.67
kr 15000.24kr 166.67
kr 1998.99
60 tablet
Free AirMail shipping Hot
kr 177.78
kr 10666.68kr 177.78
kr 666.15
30 tablet
Free AirMail shipping Hot
kr 188.88
kr 5666.41kr 188.88
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 200.00
kr 18000.40kr 200.00
kr 998.94
60 tablet
Free AirMail shipping Hot
kr 205.56
kr 12333.43kr 205.56
kr 332.80
30 tablet
Free AirMail shipping Hot
kr 211.10
kr 6333.11kr 211.10
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 238.90
kr 21500.58kr 238.90
kr 998.94
60 tablet
Free AirMail shipping Hot
kr 244.45
kr 14666.89kr 244.45
kr 332.80
30 tablet
Free AirMail shipping Hot
kr 249.99
kr 7499.84kr 249.99
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.